Low fibrinogen means your blood has insufficient levels of a key protein required to form clots, increasing the risk of uncontrolled bleeding. This condition can result from genetic disorders, severe liver disease, or acute conditions like disseminated intravascular coagulation (DIC).
Fibrinogen is produced in the liver and circulates in the bloodstream. When injury occurs, it converts into fibrin strands that bind platelets and red blood cells to create a stable clot. Normal levels range between 200-400 mg/dL. Levels below 100 mg/dL are considered clinically significant and require investigation.
A 2021 study published in Blood Advances found that patients with fibrinogen levels below 150 mg/dL had a 3.2-fold higher risk of major hemorrhage during surgery compared to those with normal levels. This underscores the clinical importance of monitoring fibrinogen, especially in trauma and perioperative settings.
Fibrinogen is the final substrate in the coagulation cascade. Once activated by thrombin, it forms long, insoluble fibrin polymers that stabilize the initial platelet plug. Without enough fibrinogen, this network fails to form properly, leading to weak clots that break apart easily.
For example, a patient with a traumatic brain injury who also has low fibrinogen may develop worsening intracranial bleeding despite normal platelet counts. In such cases, fibrinogen replacement therapy is often initiated early to prevent fatal hemorrhage.
Unlike platelet dysfunction, which causes petechiae and mucosal bleeding, low fibrinogen typically presents with deeper tissue bleeding-such as hematomas, joint bleeds, or prolonged oozing after minor cuts. These signs often appear after invasive procedures or spontaneous bruising.
The most frequent causes fall into three categories: consumption, decreased production, and inherited deficiency.
| Type | Examples | Key Mechanism |
|---|---|---|
| Consumption | DIC, severe sepsis, massive trauma | Excessive activation of coagulation consumes fibrinogen faster than the liver can replace it. |
| Decreased Production | Liver cirrhosis, malnutrition, acute hepatitis | Liver damage reduces synthesis of clotting factors, including fibrinogen. |
| Inherited Deficiency | afibrinogenemia, hypofibrinogenemia | Genetic mutations in the FGG gene impair fibrinogen formation. |
Disseminated intravascular coagulation (DIC) is the most common acquired cause. In DIC, widespread microclots form throughout the body, depleting fibrinogen and other clotting proteins. A patient with septic shock may show low fibrinogen alongside elevated D-dimer and prolonged PT/INR.
Low fibrinogen is not always due to illness. Some people have mild, stable reductions due to genetics. A 2019 review in Thrombosis and Haemostasis noted that up to 1 in 10,000 individuals have congenital afibrinogenemia, a rare autosomal recessive disorder causing lifelong bleeding episodes.
Low fibrinogen is often mistaken for low platelet count (thrombocytopenia) or deficiencies in other clotting factors like factor VIII. However, the underlying mechanisms differ.
While both conditions increase bleeding risk, platelet disorders typically cause petechiae and easy bruising. Fibrinogen deficiency leads to poor wound healing and delayed clot formation-especially noticeable in surgical sites or after dental work.
Another confusion arises with low albumin. Both are serum proteins, but albumin maintains oncotic pressure and fluid balance. A low fibrinogen level does not affect edema or ascites, unlike low albumin.
One non-obvious distinction: fibrinogen levels can drop rapidly in acute illness. A patient with severe pneumonia may see fibrinogen fall from 300 mg/dL to 80 mg/dL within 24 hours. This decline often precedes other coagulation abnormalities, making it an early warning sign of systemic inflammation.
Diagnosis begins with a fibrinogen assay-a specialized test run on plasma samples. The test is usually ordered when a patient shows prolonged clotting times (PT/INR, aPTT) or unexplained bleeding.
For example, a 62-year-old woman admitted with gastrointestinal bleeding had a fibrinogen level of 65 mg/dL. Her PT was 18 seconds (normal 11-15), and her D-dimer was 12,000 ng/mL. These findings pointed to DIC secondary to a ruptured abdominal aortic aneurysm. She received cryoprecipitate (rich in fibrinogen) and survived after emergency surgery.
Treatment depends on the cause. In DIC, managing the underlying trigger-like antibiotics for sepsis-is critical. In liver failure, supportive care and vitamin K may help, but fibrinogen replacement is often needed. For congenital deficiency, prophylactic infusions are used before surgery or childbirth.
Fibrinogen supplementation is not always effective. A 2020 trial in JAMA Surgery showed that administering fibrinogen concentrate improved outcomes in trauma patients only when levels were below 100 mg/dL. Patients with levels above 100 mg/dL saw no benefit and higher rates of thrombotic events.
If you have a history of excessive bleeding after minor injuries, frequent nosebleeds, or prolonged menstrual bleeding, discuss low fibrinogen with your doctor. Routine labs may catch it incidentally during pre-op screening or routine blood tests.
I once observed a patient with undiagnosed hypofibrinogenemia who bled heavily after a routine colonoscopy. His fibrinogen was 70 mg/dL-well below normal. After receiving cryoprecipitate, his bleeding stopped. He later learned he had a heterozygous mutation in the FGA gene, confirming a mild inherited deficiency.
Low fibrinogen means your body lacks a important component for stopping bleeding. Identifying the root cause-whether genetic, acute, or chronic-is essential for appropriate treatment and prevention of complications.